Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Miloš Hroch

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Biomedical Chromatography : BMC|November 19, 2015
LC-MS/MS method for the determination of haemanthamine in rat plasma, bile and urine and its application to a pilot pharmacokinetic studyMiloš Hroch, Stanislav Mičuda, Radim Havelek, et al.
Journal of Pharmaceutical and Biomedical Analysis|August 16, 2020
In vitro and in vivo metabolism of 3-quinuclidinyl benzilate by high-resolution mass spectrometryMartin Uher, Martin Mžik, Jana Žďárová Karasová, et al.
Clinical Pharmacokinetics|December 16, 2014
Kinetically guided neoadjuvant chemoradiotherapy based on 5-Fluorouracil in patients with locally advanced rectal cancerJiří Grim, Miloš Hroch, Hroch Miloš, et al.
Toxicology|July 9, 2013
Early and delayed cardioprotective intervention with dexrazoxane each show different potential for prevention of chronic anthracycline cardiotoxicity in rabbitsEduard Jirkovský, Olga Lenčová-Popelová, Miloš Hroch, et al.
Planta Medica|September 10, 2016
Boldine Inhibits Mouse Mammary Carcinoma In Vivo and Human MCF-7 Breast Cancer Cells In VitroPavel Tomšík, Stanislav Mičuda, Darina Muthná, et al.
Journal of Molecular and Cellular Cardiology|January 3, 2016
Cardioprotective effects of inorganic nitrate/nitrite in chronic anthracycline cardiotoxicity: Comparison with dexrazoxaneOlga Lenčová-Popelová, Eduard Jirkovský, Hana Jansová, et al.
Toxicology|November 7, 2016
Are cardioprotective effects of NO-releasing drug molsidomine translatable to chronic anthracycline cardiotoxicity settings?Olga Lenčová-Popelová, Hana Jansová, Eduard Jirkovský, et al.
Nature Communications|February 6, 2025
The hypolipidemic effect of MI-883, the combined CAR agonist/ PXR antagonist, in diet-induced hypercholesterolemia modelJan Dusek, Ivana Mejdrová, Klára Dohnalová, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Biomedical Chromatography : BMC|November 19, 2015
LC-MS/MS method for the determination of haemanthamine in rat plasma, bile and urine and its application to a pilot pharmacokinetic studyMiloš Hroch, Stanislav Mičuda, Radim Havelek, et al.
Journal of Pharmaceutical and Biomedical Analysis|August 16, 2020
In vitro and in vivo metabolism of 3-quinuclidinyl benzilate by high-resolution mass spectrometryMartin Uher, Martin Mžik, Jana Žďárová Karasová, et al.
Clinical Pharmacokinetics|December 16, 2014
Kinetically guided neoadjuvant chemoradiotherapy based on 5-Fluorouracil in patients with locally advanced rectal cancerJiří Grim, Miloš Hroch, Hroch Miloš, et al.
Toxicology|July 9, 2013
Early and delayed cardioprotective intervention with dexrazoxane each show different potential for prevention of chronic anthracycline cardiotoxicity in rabbitsEduard Jirkovský, Olga Lenčová-Popelová, Miloš Hroch, et al.
Planta Medica|September 10, 2016
Boldine Inhibits Mouse Mammary Carcinoma In Vivo and Human MCF-7 Breast Cancer Cells In VitroPavel Tomšík, Stanislav Mičuda, Darina Muthná, et al.
Journal of Molecular and Cellular Cardiology|January 3, 2016
Cardioprotective effects of inorganic nitrate/nitrite in chronic anthracycline cardiotoxicity: Comparison with dexrazoxaneOlga Lenčová-Popelová, Eduard Jirkovský, Hana Jansová, et al.
Toxicology|November 7, 2016
Are cardioprotective effects of NO-releasing drug molsidomine translatable to chronic anthracycline cardiotoxicity settings?Olga Lenčová-Popelová, Hana Jansová, Eduard Jirkovský, et al.
Nature Communications|February 6, 2025
The hypolipidemic effect of MI-883, the combined CAR agonist/ PXR antagonist, in diet-induced hypercholesterolemia modelJan Dusek, Ivana Mejdrová, Klára Dohnalová, et al.
Pageof 2